Viewing Study NCT01891357


Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2025-12-25 @ 4:12 PM
Study NCT ID: NCT01891357
Status: TERMINATED
Last Update Posted: 2019-09-17
First Post: 2013-05-14
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Sponsor: West German Study Group
Organization: